Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 2;61(2):2201797.
doi: 10.1183/13993003.01797-2022. Print 2023 Feb.

Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!

Affiliations
Free article
Editorial

Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!

David Gozal et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: D. Gozal has no conflicts of interest to disclose. M. Kolb reports being site PI for sponsored clinical trials for Roche and Boehringer Ingelheim, grants from Canadian Institute for Health Research, grants and personal fees for advisory board work from Boehringer Ingelheim and Roche Canada, chief editor allowance from the European Respiratory Society, personal fees for advisory board work from Horizon, Algernon, CSL Behring, DevPro, Bellerophon and BMS, personal fees for adjudication committee work from United Therapeutics, and personal fees for data monitoring committee work from LabCorp, outside the submitted work.

Comment on

  • Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
    Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR, Brown KK, Dumistracel M, Erhardt E, Bertulis J, Gahlemann M, Stowasser S, Griese M; InPedILD trial investigators. Deterding R, et al. Eur Respir J. 2023 Feb 2;61(2):2201512. doi: 10.1183/13993003.01512-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36041751 Free PMC article. Clinical Trial.

LinkOut - more resources